Medical network May 19 - on May 17th, administration of drug safety device whose center released 2017 4, review the results of the public, to agree to 7 products to the innovation of medical equipment special approval process. 

 

Include: 

 

Product name: low temperature plasma operating system 

 

Applicant: Beijing nortes technology co., LTD 

 

Product name: quantitative blood flow score measurement system 

 

Applicant: bo mobile medical imaging technology (Shanghai) co., LTD 

 

Product name: adsorbed blood dialysis system 

 

Applicant: medtronic medical instrument (chengdu) co., LTD 

 

Product name: positron emission tomography and magnetic resonance imaging system 

 

Applicant: Shanghai lianfilm medical technology co., LTD 

 

Product name: the bioabsorber of the coronary artery rapamycin elutriate the stent system 

 

Applicant: Beijing amet medical device co., LTD 

 

Product name: bioabsorber of the coronary artery rapamycin elutriate the stent system 

 

Applicant: shenzhen xinlitai bio-medical engineering co., LTD 

 

Product name: near-infrared fluorescence imaging system 

 

Applicant: Beijing digital precision medical technology co., LTD 

 

, according to the blue parker instruments since 2017, the administration of drug safety device has released four public trial center, agreed to as many as 37 innovative medical device products access to special examination and approval. 

 

And in all of 2016, the fda has identified 45 products to enter the special approval channel for innovative medical devices. 

 

Obviously, this year, review of medical equipment examination and approval reform efforts is greatly increased, the year into the special channel and the innovation of the approved listing YiXie product quantity, also should be going to the roof.